{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : true,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0008283",
      "entity_text" : "proliferation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04457",
      "entity_text" : "commercial anti-TM4SF5 antibody",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "However, the commercial anti-TM4SF5 antibody (sc-165713) did not reduce the proliferation of TM4SF5 expressing cancer cells.",
  "reading_complete" : "2020-08-02T12:36:39Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T12:35:17Z",
  "trigger" : "reduce",
  "evidence" : [ "commercial anti-TM4SF5 antibody (sc-165713) did not reduce the proliferation" ],
  "pmc_id" : "5327636",
  "score" : 0
}